Rapid Dose Therapeutics Corp's market cap is currently C$24.40M. The company's EPS TTM is C$-0.047; its P/E ratio is ―; Rapid Dose Therapeutics Corp is scheduled to report earnings on February 3, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	C$ 1.02M	C$ 718.30K	C$ 1.75M	C$ 262.81K	C$ 101.50K
Gross Profit	C$ 563.41K	C$ 372.40K	C$ 1.34M	C$ 207.45K	C$ 37.34K
Operating Income	C$ -3.74M	C$ -3.54M	C$ -4.30M	C$ -2.13M	C$ -7.51M
EBITDA	C$ -3.02M	C$ -2.92M	C$ -7.59M	C$ -987.23K	C$ -7.37M
Net Income	C$ -4.31M	C$ -3.81M	C$ -12.55M	C$ -2.44M	C$ -8.16M
Balance Sheet
Cash & Short-Term Investments	C$ 161.06K	C$ 27.59K	C$ 34.44K	C$ 70.26K	C$ 3.47K
Total Assets	C$ 1.89M	C$ 2.25M	C$ 3.07M	C$ 3.83M	C$ 4.29M
Total Debt	C$ 2.45M	C$ 1.61M	C$ 1.17M	C$ 2.06M	C$ 1.22M
Net Debt	C$ 2.29M	C$ 1.58M	C$ 1.14M	C$ 1.99M	C$ 1.22M
Total Liabilities	C$ 5.04M	C$ 4.92M	C$ 2.82M	C$ 5.41M	C$ 4.44M
Stockholders' Equity	C$ -3.16M	C$ -2.67M	C$ 251.56K	C$ -1.58M	C$ -147.78K
Cash Flow
Free Cash Flow	C$ -2.29M	C$ -863.92K	C$ -3.04M	C$ -1.63M	C$ -4.26M
Operating Cash Flow	C$ -2.29M	C$ -863.92K	C$ -3.00M	C$ -1.62M	C$ -3.03M
Investing Cash Flow	C$ 0.00	C$ 0.00	C$ 1.85M	C$ -9.12K	C$ 530.46K
Financing Cash Flow	C$ 2.43M	C$ 856.53K	C$ 1.13M	C$ 1.65M	C$ 1.24M

Currency in CAD

Rapid Dose Therapeutics Corp Earnings and Revenue History

Income Statement >

Rapid Dose Therapeutics Corp Debt to Assets

Balance Sheet >

Rapid Dose Therapeutics Corp Cash Flow

Cash Flow >

Rapid Dose Therapeutics Corp Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing